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ABSTRACT 
Title: Anesthesia Considerations for Intraoperative Blood Transfusion 
Background: Bleeding during surgery is inevitable. Blood transfusions are commonly 
administered intraoperatively in effort to maintain adequate oxygenation of vital organs; 
however, blood transfusions are not without considerable risk. Hence, anesthesia professionals 
should be made aware of when blood transfusion may be of more benefit than harm.  
Purpose: The purpose of this independent study is to provide a case report as well as an 
extensive review of the current evidence on administering blood transfusions during the 
intraoperative period for the surgical patient.  
Process: A review of the literature was performed using PubMed and the Cochrane Library 
databases from the University of North Dakota’s Health Sciences Library. Each reference was 
carefully selected for inclusion in this review, which was conducted between September 2016 
and February 2017.  
Results: Anesthesia professionals must ensure patients are optimized prior to surgery in effort to 
minimize blood loss and prevent the need for intraoperative blood transfusion. Current literature 
supports restrictive versus liberal transfusion. Specific guidelines regarding intraoperative 
transfusion are vague and leave much room for anesthesia professionals judgement. In the event 
that massive transfusion of blood products is required, it is recommended to transfuse a high 
ratio of fresh frozen plasma (FFP)/red blood cell (RBC) and platelet (PLT)/RBC.  
Implications: Morbidity and mortality of patients may be decreased if anesthesia providers are 
knowledgeable about surgical transfusion practices. 
Keywords: Blood transfusion, massive transfusion, transfusion ratios, survival, mortality, 
surgery, and noncardiac surgery.  
INTRAOPERATIVE BLOOD TRANFUSION                                                                            4 
 
Anesthesia Considerations for Intraoperative Blood Transfusion  
 The Joint Commission (2012) identified RBC transfusion as one of the most overused 
interventions performed in the United States. Blood loss during surgery is likely; the degree can 
vary depending on the surgery and individual patient factors. Thus, it is of no large surprise that 
most RBC transfusions in the United States occur in surgical patients (US Department of Health 
and Human Services, as cited by Qian et al., 2013). Certainly, intraoperative blood transfusion 
may be life-saving at times; however, blood transfusion is not a benign intervention. Blood 
transfusions have been associated with immunomodulation, which may cause several other 
complications. In addition, blood transfusions contribute significantly to healthcare costs. In 
2010, the cost of a single unit of red blood cells (RBCs) from acquisition to transfusion was 
estimated to be between $1,600 - $2,400 (Wu et al., 2010). Addressing surgical blood 
management will not only affect patient safety, but healthcare costs as well (Ferraris et al., 
2011).   
Estimated blood loss for a radical nephrectomy is approximately 500ml. However, if the 
renal vein or inferior vena cava (IVC) is involved, the complexity of the surgery is increased and 
the chances of intraoperative complications, such as bleeding, are greater. A team approach, 
which includes cardiothoracic surgery, may be utilized if the tumor significantly involves the 
IVC as the patient may require cardiopulmonary bypass under hypothermia as the ICV is 
clamped (Jaffe, Schmiesing, and Golianu, 2014).  
The decision to transfuse blood must not be made frivolously. Rather, the benefits versus 
the risks of transfusion must be carefully considered based on the individual patient and 
particular situation. In the following pages, a case report of an elderly man with renal 
malignancy, which required intraoperative blood transfusion, while undergoing a radical robotic 
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nephrectomy is presented. A review of literature regarding transfusion practice during the 
intraoperative period for surgical patients will then be presented.    
Purpose 
 The purpose of this independent project is to review a case report and provide anesthesia 
professionals with evidence-based research regarding blood transfusion in the noncardiac 
surgical patient. By understanding when intraoperative transfusion is warranted, morbidity and 
mortality rates associated with intraoperative blood transfusion may be reduced. Thus, anesthesia 
professionals may improve surgical patient outcomes by being knowledgeable in appropriate 
transfusion practices.  
Case Report 
 A 65-year-old, 110 kg, 175 cm, Caucasian male presented for a right radical robotic 
(possibly open) nephrectomy for the treatment of primary kidney cancer with metastasis to the 
lung. The surgery was elective with the intent as being cytoreductive rather than curative. Prior 
to surgery, the patient had a coil placed in his right renal artery to decrease the potential for 
intraoperative bleeding. He denied having any allergies. His medical history was significant for 
hypertension, diabetes mellitus type 2, and a cerebrovascular accident (CVA) in 2013. Surgical 
history included tonsillectomy, bronchoscopy, and an endobronchial ultrasound. There was no 
history of anesthetic complications. Current medications included aspirin, fish oil, tamsulosin, 
insulin glargine, lisinopril, amlodipine, and clonidine.  
 The patient was considered an American Society of Anesthesiologists physical status 
level three. He was a Mallampati class II with full neck range of motion and no notable dental 
history or viable issues. His preoperative electrocardiogram (EKG) showed normal sinus rhythm. 
Preoperative vital signs were: blood pressure 166/72, heart rate 72, respirations 20, pulse 
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oximetry 90% on room air, and temperature 36.9° Celsius. His preoperative labs were as follows: 
hemoglobin 14.2 g/dL, hematocrit 42.5%, platelets 187,000 per mcL, PT 10.4 seconds, PTT 23.8 
seconds, INR 0.97, BUN 25 mg/dL, creatinine 1.56 mg/dL, CO2 20 mEq/L, Na 138 mEq/L, Cl 
100 mEq/L, K 3.7 mEq/L, and glucose 149 mg/dL. The patient’s blood type was AB positive 
without antibodies. Two units of RBCs had been typed and cross matched prior to surgery and 
were available.  
 In the preoperative holding room, a 20-gauge peripheral intravenous (IV) catheter was 
started in the patient’s right antecubital area. A 1L bag infusion of lactated ringer’s solution was 
begun and midazolam 2mg was given IV. The patient was transported to the operating room 
(OR) by a registered nurse, certified registered nurse anesthetist, and a student registered nurse 
anesthetist. Upon arrival to the OR, the patient was assisted to the operating table and standard 
non-invasive monitors were applied.   
 The patient was pre-oxygenated via face mask at 8 liters per minute (LPM) for 
approximately three minutes. For induction, fentanyl 50mcg, lidocaine 50mg, propofol 200mg, 
and cisatracurium 20mg were given. The patient was intubated via direct laryngoscopy using a 
Macintosh 3 blade. A grade I view was obtained and a 7.5mm cuffed endotracheal tube (ETT) 
was visualized passing through the vocal cords without difficulty. After intubation, bilateral 
breath sounds were auscultated. End-tidal carbon dioxide (ETCO2) monitoring was present and 
the ETT was secured in place with tape. The patient was placed on mechanical ventilation and 
desflurane was initiated with end-tidal concentrations of 6-7%. Initial fresh gas flows were 1 
LPM of air and 1 LPM of oxygen. A nasopharyngeal temperature probe was inserted into the 
right nare and a bispectral index (BIS) monitor was applied to his forehead. The left radial artery 
was cannulated with a 20-gauge arterial line without ultrasound guidance and a 16-gauge 
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peripheral IV catheter was inserted in the left hand. A 1L bag of 0.9% sodium chloride with 
blood tubing on a fluid warmer was attached to the newly placed IV. A Foley catheter was 
inserted by the registered nurse.  
 The patient was repositioned in the left lateral decubitus position with a sandbag and the 
kidney rest up. An upper Bair hugger was placed across his thorax and arms as he was sterilely 
prepped, draped, and the robot was positioned into place. Prior to incision cefazolin 2g as well as 
famotidine 20mg, metoclopramide 5mg, dexamethasone 10mg, and ondansetron 4mg were 
given. 
 Approximately three hours into the operation, general surgery was consulted due to the 
tumors proximity and adherence to the hepatic flexure of the bowel. Three options were 
presented: have general surgery assist and perform a bowel resection, abort the surgery as it was 
not intended to be curative, or have urology continue attempting to dissect the tumor away from 
the bowel. At that time, the decision for urology to proceed without general surgery was made. 
After another hour passed, the urologist decided to convert to an open radical nephrectomy due 
to tumor size and involvement with surrounding tissues. The robot was removed from position as 
the surgeon scrubbed and sterilely donned a gown and gloves. At that point, the patient remained 
hemodynamically stable with negligible blood loss. Mild hypoglycemia (75 mg/dL) had been 
corrected with dextrose 25g.  
 Roughly 30 minutes after converting to an open procedure, the surgeon notified the 
anesthesia team about blood loss and he determined that the IVC had been inadvertently incised. 
The blood bank was immediately called and the 2 units of RBCs that had been typed and cross 
matched were sent to the OR. In the meantime, the surgeon attempted to contain the bleeding by 
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holding his fingers over the opening in the IVC, while anesthesia rapidly infused the two liters of 
crystalloid that were hanging.  
The previously consulted general surgeon came to assist, while waiting for the vascular 
surgeon to arrive. A transesophageal echocardiogram (TEE) was performed by the 
anesthesiologist, which showed an empty left ventricle. Simultaneously, several units of RBCs 
were transfused, as well as infusion of several liters of crystalloid and colloid. IV boluses of 
epinephrine, phenylephrine, ephedrine, and vasopressin were given as well as calcium gluconate 
4g, and a total of 300mEq of sodium bicarbonate. Eventually, phenylephrine and epinephrine 
infusions were initiated and the desflurane was stopped due to severe hemodynamic instability. 
Two subsequent doses of cisatracurium, 10mg each, were given to prevent any patient 
movement. After receiving no sedation for an extended period, the patient’s BIS reading was 
between 3-10.  
A total of 12 units of RBCs, 3 units of PLT, and 1 unit of FFP were transfused in the OR. 
Total estimated blood loss in the OR was approximately 8,000ml and the patient’s estimated 
total blood volume was 8,260ml. Total urine output at the end of surgery was 430ml.  
Once the bleeding was controlled, the patient was transferred to the critical care unit 
(CCU). The anesthesia team determined that the patient would remain intubated upon transfer. 
The transfusions of blood products and infusions of vasopressors were continued as the patient 
was transferred to the CCU. Upon arrival to the CCU, the patient cardiac arrested. One round of 
cardiopulmonary resuscitation was performed. A single lumen right femoral central line was 
placed by the general surgeon for increased IV access and care was turned over to the critical 
care physician.  
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Two days after the surgery, the patient was extubated. On the third postoperative day, he 
was transferred out of the CCU to a general floor. The patient’s mental status had returned to 
baseline; he was alert and oriented to person, place, and time. 
Literature Search 
 An online review of current evidence was completed using the University of North 
Dakota’s Health Sciences Library website. The criteria for inclusion were: publication date 
within the past 5 years, availability in English, and human subjects. Knowing that significant 
vasculature, such as the IVC, may be involved during a nephrectomy, the initial focus was blood 
loss and transfusion during a radical nephrectomy as well as associated morbidity and mortality. 
However, several preliminary searches involving such focus were without avail. Failed searches 
performed on PubMed included the medical subject heading (MeSH) terms: nephrectomy 
(adverse effects, complications, mortality), robotic, kidney neoplasms, renal cell carcinoma, 
bleeding, blood transfusion, hemorrhage, blood component transfusion, and vena cava in various 
combinations. Similar searches were performed on CINAHL using CINHAL headings without 
success. A research and education librarian from the Library of Health Sciences at the University 
of North Dakota was contacted for assistance with the literature search. Likewise, the searches 
by the librarian yielded insufficient results.  
 The scope of the literature review was broadened to include intraoperative transfusion of 
patients undergoing general noncardiac surgery and associated morbidity and mortality. PubMed 
was searched with the MeSH terms blood transfusion (standards, surgery) and surgical blood 
loss. The search yielded 13 articles, one of which was selected for inclusion. A link of similar 
articles was provided which contained 104 results. When the inclusion criteria were applied 
(publication date within the past 5 years, availability in English, and human subjects), 41 results 
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remained, six of which were selected for review. One article of particular interest contained a 
link to similar articles; inclusion criteria remaining, 402 articles were available for review. 
Thirteen applicable articles were carefully selected.  
Additional journal articles were found by reviewing the reference lists of the 
aforementioned articles. Articles which met the inclusion criteria were selected, except for 
certain recurring references or more specific articles of interest, which had publication dates 
outside of the past 5 years. The average publication date of the older selected articles (5) was 6.6 
years. Each selected article was found by typing in the title in the search field of PubMed or the 
Cochrane Library. After the above selection process and careful consideration of each article, a 
total of 23 articles were selected for inclusion in this literature review.   
Discussion 
It is well known that RBCs are needed to carry oxygen to the tissues. In a state of anemia, 
less oxygen is readily available to be exchanged and the body attempts to compensate by 
increasing cardiac output. The elderly, such as the patient presented in the case report, have less 
physiological reserve and may be unable to compensate adequately. Additionally, the workload 
of the heart is greater, which may be deleterious to an already ailing heart. Blood is transfused in 
effort to increase hemoglobin concentration; subsequently, increasing oxygen delivery while 
decreasing the demand on the heart (Carson et al., 2016).  
Patients may be anemic for various reasons: iron deficiency, renal disease, cancer, and 
perhaps the most common reason intraoperatively, surgical blood loss. Blood transfusion is the 
most common treatment for anemia and despite the expense, may be overused (Glance et al., 
2011; Mastracci et al., 2012, Smilowitz et al., 2016). The overuse of blood transfusion may 
negatively impact the health of surgical patients (Qian et al, 2013). Adverse effects, such as 
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immunomodulation, may be particularly detrimental in already immunocompromised patients, 
such as those with malignancy. Consequently, it is important to understand when transfusion is 
in the best interest of the patient versus when it is not. Various researchers have explored this 
matter in attempt to determine best practice guidelines.  
The elderly patient in this case report had renal disease, cancer, and underwent a right 
radical nephrectomy which placed him at an increased risk for preoperative anemia and 
significant blood loss. He had not yet started radiation/chemotherapy, which would have caused 
him to become substantially immunocompromised, increasing the risks associated with blood 
transfusion. His history of chronic hypertension may have resulted in a rightward shift in his 
cerebral autoregulation curve; resulting in higher mean arterial pressure (MAP) required to 
maintain constant cerebral blood flow. Also, his history of a previous CVA and diabetes placed 
him at an increased risk of poor neurological outcomes in the event of decreased perfusion to the 
brain. 
Transfusion Thresholds: Blood Loss and Anemia   
 Wu et al. (2010) retrospectively examined 239,286 older patients (>65 years) at the 
Veteran Affairs (VA) hospitals with the intent of determining an association between 
intraoperative blood transfusion and 30-day postoperative mortality. The study included eight 
surgical specialties: general, vascular, orthopedics, urology, noncardiac thoracic, neurosurgery, 
otolaryngology, and plastic surgery. It was found that patients benefited from transfusion if they 
had “substantial” operative blood loss (>500ml) or a low preoperative hematocrit (<24%). 
However, transfusion in patients who did not have substantial blood loss or had a preoperative 
hematocrit between 30-35.9% had an associated increase in mortality.  
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Based on the framework of the previously discussed study, Wu et al. (2012) again 
retrospectively studied 46,608 older patients (>65 years) who received an intraoperative 
transfusion when undergoing major noncardiac surgery at a VA hospital. In this study, the 
relationship between hospital rates of transfusion in patients experiencing significant (>500ml) 
blood loss and 30-day mortality was examined. The researchers found that hospitals which 
transfused patients with significant blood loss had lower risk adjusted 30-day postoperative 
mortality rates.  
Likewise, in a retrospective observational study, Chen et al. (2015) examined 424,015 
older patients (>65 years) who received an intraoperative blood transfusion while undergoing 
noncardiac surgery at a VA hospital. The relationship between intraoperative blood transfusion 
and 30-day risk adjusted postoperative mortality was examined at a hospital-level. The study 
concluded that hospitals which transfused patients with an indication for transfusion 
(preoperative hematocrit <24% or surgical blood loss >500 ml), had lower risk adjusted 30-day 
postoperative mortality rates. 
 Smilowitz et al. (2016) also conducted a retrospective cohort study of 3,050 patients 
undergoing major orthopedic surgery: hip, knee, and spine surgery. The average patient age was 
60.8 years and approximately 41% of the subjects were male. Patients with a higher preoperative 
hemoglobin had higher associated mortality risk with transfusion, while those with lower 
preoperative hemoglobin levels did not: the hazard ratio of patients with no preoperative anemia 
(hemoglobin 12 or > in women, 13 or > in men) was 4.39 versus 0.81 in patients with 
moderate/severe anemia (hemoglobin <9). 
 Likewise, Saager et al. (2013) also researched preoperative anemia and the association 
with 30-day postoperative mortality rates. The American College of Surgeons National Surgical 
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Quality Improvement Project (ACS-NSQI) database was used to perform a retrospective 
analysis. A total of 574,860 noncardiac surgical patients, which underwent propensity matching, 
were included in the study. Trauma and pediatric patients are not included in the database and 
were subsequently not included in this study or others using the ACS-NSQIP database. 
Approximately 25% of patients had baseline anemia; anemia in this study was defined as 
hematocrit <36% in women and <39% in men. Preoperative anemia was independently 
associated with increased postoperative mortality rates. Saager et al. (2013) suggests that 
transfusion of blood prior to surgery may be preferable to intraoperative transfusion as 
“allogeneic blood transfusion compromises the immune system as well and might cause a second 
hit to an already weakened immune system when performed in the intraoperative period” (p 
914).  
Low Volume Transfusion  
Bernard, Davenport, Chang, Vaughan, and Zwischenberger (2009) queried the ACS-
NSQIP database to evaluate the effect of low volume intraoperative blood transfusion (1 to 2 
units) of RBCs on morbidity and mortality of patients undergoing general surgery. The study 
was a prospective, systematic study that included 125,177 patients undergoing noncardiac 
general surgery. The mean age of patients included in the study was 52.9 years, approximately 
40% of which were male. The study concluded that transfusion of merely 1 or 2 units of RBCs 
intraoperatively increases morbidity and mortality.  
Similarly, Ferraris et al. (2011), also utilized the ACS-NSQIP database to conduct an 
exploratory observational study of patients undergoing noncardiac, nonvascular thoracic surgery. 
Patients were further divided into three groups based on type of surgery: lung/pleura/chest wall, 
nonvascular within the mediastinum, and esophageal operations. A total of 8,728 patients, which 
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were propensity-matched, were included in this study. The effect of small amounts (1 or 2 units) 
of intraoperative RBC transfusion on 30-day morbidity and mortality was evaluated. The results 
of this study were much like those of Bernard et al. (2009); overall, morbidity and mortality were 
increased with transfusion of 1 or 2 units of RBCs.  
Ferraris, Davenport, Saha, Austin, and Zwischenberger (2012), also used the ACS-
NSQIP to compare patients undergoing noncardiac operations who received 1 unit of RBCs 
intraoperatively versus both patients who did not receive an intraoperative transfusion and those 
who received more than 1 unit of RBCs. A total of 941,496 patients, which were propensity-
matched, were included in this longitudinal, uncontrolled observational study. The findings 
supported an association between intraoperative transfusion of 1 unit of RBCs and morbidity, 
especially infectious complications such as wound infections, pneumonias, and sepsis.   
Lastly, Glance et al. (2011) performed a retrospective analysis using the ACS-NSQIP 
database to observe the association between intraoperative transfusion of 1 or 2 units of RBCs 
and morbidity and mortality in patients with “severe” baseline anemia (hematocrit <30%) 
undergoing noncardiac surgery: general, vascular, and orthopedic surgery. The study included 
10,100 patients. Patients who received 1 or 2 units of RBCs intraoperatively were compared to 
those who did not receive a transfusion. Transfused patients experienced a higher 30-day 
mortality rate in this observational study. 
Transfusion within 72 Hours  
 Abdelsattar, Hendren, Wong, Campbell, and Henke (2015), studied the effect of blood 
transfusion within 72 hours of surgery on 30-day mortality in patients greater than 18 years 
undergoing vascular or general abdominal surgery. Information obtained for the study stemmed 
from the Michigan Surgical Quality Collaborative (MSQC), which includes 52 hospitals. A total 
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of 2,243 patients who received a RBC transfusion within 72 hours were included in this 
propensity score matched observational study. Overall, patients which received a postoperative 
blood transfusion had increased rates of 30-day mortality; paradoxically, an exception to these 
findings was an associated decreased risk of myocardial infarction.  
 Ferraris, Hochstetler, Martin, Mahan, and Saha (2015), used the ACS-NSQIP database to 
evaluate the effect that blood transfusion within 72 hours of surgery had on operative outcomes. 
The records from more than 300 acute care hospitals were analyzed. The intent of this 
observational study was to identify patients which may be “helped” from transfusion versus 
those that would be “harmed”. Patients undergoing cardiothoracic, vascular, neurosurgery, or 
general surgery were included in the study. Patients who underwent cardiac surgery were 
excluded from analysis. A total of 470,407 patients were included in the study, 32,953 of which 
received a transfusion within 72 hours of surgery. Predicted operative mortality was calculated 
for each patient based on various preoperative variables such as age, ASA class, preoperative 
illness (pneumonia, sepsis), steroid use, preoperative cancer diagnosis, preexisting bleeding 
disorder, etc. It was discovered that patients which were the most “high-risk” did not have 
significant risk with blood transfusion; however, “low-risk” patients had a substantially increased 
risk of morbidity associated with blood transfusion. The researchers posit that careful 
preoperative evaluation of transfusion risk and proper intervention prior to elective procedures 
may decrease morbidity and mortality associated with blood transfusion.   
Cancer and Immunomodulation 
Al-Refaie, Parsons, Markin, Abrams, and Habermann (2012) specifically looked at the 
effect of blood transfusion on cancer surgery outcomes. The ACS-NSQIP was utilized to identify 
38,926 patients >18 years of age who underwent surgical resection for thoracic, abdominal, or 
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pelvic neoplasms. Approximately 60% of patients included in this prospective study received 
only 1 or 2 units or RBCs. Overall, intraoperative blood transfusion was found to have adverse 
effects on surgical outcomes, including 30-day postoperative mortality. Unlike other studies, 
such as those performed by Wu et al. (2010) and Chen et al. (2015), blood transfusion was 
shown to have adverse effects despite a low or normal hematocrit level.  
 Ferraris, Ballert, and Mahan (2013) utilized the ACS-NQIP database to retrospectively 
explore the relationship between intraoperative blood transfusion and the development of 
systemic inflammatory response syndrome (SIRS). Patients who underwent outpatient 
procedures were excluded from the study. A total of 553,288 patients were included in the study, 
40,378 of which received an intraoperative blood transfusion. The development of SIRS may 
increase the risk of patients developing serious complications such as respiratory failure and 
multiple organ dysfunction. After propensity-matching of risk factors, transfused patients had 
increased rates of morbidity, including SIRS, and mortality. Most patients in this study received 
1 or 2 units of RBCs. The researchers conclude that limiting intraoperative transfusion may 
improve patient outcomes by decreasing the risk of developing SIRS.   
Blood Loss Prevention  
 Some bleeding during surgery is to be expected; however certain precautions may be 
taken to decrease the occurrence of major bleeding. For non-emergent surgeries, such 
precautions should be initiated long before the patient arrives in the OR. Prudent anesthesia 
professionals should carefully review previous medical records as well as conduct a thorough 
interview of the patient. Information obtained should include history of previous blood 
transfusions, drug-induced or congenital coagulopathies, thrombotic events, as well as risk 
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factors for organ ischemia (American Society of Anesthesiologists Task Force on Perioperative 
Blood Management, 2015).  
Anticoagulation medications should also be discontinued as appropriate; the risk of 
thrombosis versus the risk of bleeding must always be carefully considered. The American 
Society of Anesthesiologists Task Force on Perioperative Blood Management (2015) has 
developed the following specific guidelines regarding anticoagulation therapy:  
In consultation with an appropriate specialist, discontinue anticoagulation therapy (i.e. 
warfarin, anti-Xa drugs, antithrombin agents) for elective surgery.  
 Transition to shorter acting drugs (i.e. heparin, low-molecular-weight heparin) 
may be appropriate in selected patients.  
 If clinically possible, discontinue non-aspirin antiplatelet agents (i.e. 
thienopyridines such as clopidogrel, ticagrelor, or parsugrel) for sufficient time in 
advance of surgery, except for patients with a history of percutaneous coronary 
interventions.  
 Aspirin may be continued on a case-by-case basis. (p. 245)  
Additionally, erythropoietin and/or iron may be administered to treat iron deficiency anemia and 
reduce the chance of requiring an intraoperative blood transfusion. Autologous blood may also 
be donated prior to surgery (American Society of Anesthesiologists Task Force on Perioperative 
Blood Management, 2015).  
 For the case report patient, precautions were taken preemptively to decrease the chance of 
significant blood loss prior to surgery. The patient had undergone embolization of the right renal 
artery in the catheterization laboratory. Preoperative labs including hemoglobin, hematocrit, 
platelets, as well as coagulation studies were within normal range prior to surgery. Two units of 
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blood had been typed and cross matched for the patient and were readily available in the blood 
bank. A second peripheral IV was inserted for additional vascular access and a 0.9% sodium 
chloride infusion on blood tubing and a fluid warmer was begun in preparation for the event that 
transfusion was indicated. A radial arterial line was placed for vigilant hemodynamic monitoring. 
Prior to the patient arriving to the OR, a fluid table was prepared and used for guidance of fluid 
administration and urine output was monitored throughout the case. The room was routinely 
scanned for blood loss contained in canisters and saturated laparotomy pads. Vasopressors, such 
as ephedrine, phenylephrine, and vasopressin were given as needed to maintain a MAP greater 
than 70. A less invasive approach at surgery was initially attempted with the da Vinci robot; 
however, despite best attempts of the surgeon after several hours of dissecting the surgery was 
converted to an open approach. 
Intraoperative Transfusion Management   
  As Ferraris et al. (2015) stated, “Blood transfusion can be both good and bad, depending 
on the clinical situation” (p. 608). Identifying when intraoperative blood transfusion will be 
“good” for patients versus “bad” is important and may be an indicator of surgical quality (Wu et 
al., 2012). Certainly, blood transfusion may be life-saving at times, especially in the case of an 
actively hemorrhaging patient, such as was in the presented case. As discussed previously, in a 
study by Chen et al. (2015) and Wu et al. (2012), patients with an indication for transfusion, 
preoperative hematocrit <24% or surgical blood loss >500ml, had a lower 30-day risk-adjusted 
mortality if they received a blood transfusion intraoperatively.    
However, in the absence of massive bleeding or symptomatic anemia, despite the 
theoretical benefits of blood transfusion, it has not proven to be advantageous (Smilowitz et al., 
2016). Much debate over the ideal transfusion trigger has persisted in recent years. Not 
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surprisingly, there has been a wide variation in transfusion practices (Abdelsattar, et al., 2015; 
Ferraris et al., 2012; Qian et al., 2013).   
Current literature supports restrictive versus liberal transfusion. Dose-dependent 
increases in morbidity and mortality have been observed with blood transfusion (Ferraris et al., 
2012; Johnson et al., 2016). Transfusion of even small amounts, 1 or 2 units, of blood 
intraoperatively has been associated with adverse surgical outcomes (Bernard et al., 2009; 
Ferraris et al., 2011; Ferraris et al., 2012; Glance et al., 2011). In a recent Cochrane review, 
which included a wide variety of patients (surgical, critical care, acute blood loss/trauma, cancer) 
initiation of blood transfusion at a restrictive threshold (hemoglobin 7 to 8 g/dL) did not have 
adverse effects on 30-day mortality, cardiac morbidity, or infection when compared to initiation 
at a liberal threshold (hemoglobin 9-10 g/dL) (Carson et al., 2016). Transfusion guidelines 
published by The American Society of Anesthesiologist’s Task Force on Perioperative Blood 
Management (2015) remain unspecific and leaves much room for anesthesia professionals 
discretion:  
The determination of whether hemoglobin concentrations between 6 and 10 g/dl justify or 
require red blood cell transfusion should be based on potential or actual ongoing bleeding 
(rate and magnitude), intravascular volume status, signs of organ ischemia, and adequacy 
of cardiopulmonary reserve. (p. 251)  
Currently, no specific algorithm can be recommended; however, restrictive transfusion of RBCs 
may be safely implemented (The American Society of Anesthesiologist’s Task Force on 
Perioperative Blood Management, 2015).  
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Massive Transfusion  
 In the event of major surgical bleeding, as was seen in the case report, massive 
transfusion may be required. Halmin et al. (2016) identified major surgery as the most common 
indication for massive transfusion. Hence, the effects of massive transfusion on morbidity and 
mortality of the patient is of interest. It is also important to understand that not all massive 
transfusion protocols are the same. Blood component products at various facilities may be 
released in different volumes. Research regarding best component ratios during massive 
transfusion must be understood to develop protocols that will best improve patient outcomes.   
Massive transfusion has also been associated with morbidity and mortality. Turan et al. 
(2013) used the ACS-NSQIP database to prospectively collect data and examine complications 
as well as 30-day mortality rates in patients undergoing noncardiac surgery who received 
massive transfusion (5 RBC units). A total of 5,143 patients were included in the study. An 
association between massive transfusion and adverse patient outcomes was found. With each 
unit transfused, patients were estimated to have a 5% decreased chance of being discharged 
alive.  
Johnson et al. (2016) performed a retrospective analysis of medical and surgical patients 
who received high-dose transfusion (>10 units throughout hospitalization) and the association 
with patient morbidity and mortality. Approximately 3,500 patients met inclusion criteria; certain 
patient populations, such as those with hematologic malignancies were excluded from the study. 
Patients were further stratified into eight groups based on transfusion volume: 0, 1-9, 10-19, 20-
29, 30-39, 40-49, 50-75, and >75 units. Overall, mortality increased in a linear fashion as 
transfusion volume increased; approximately 10% for every 10 units of RBCs or 50% mortality 
for 50 units of transfused RBCs. However, surgical patients had decreased morbidity and 
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mortality compared to massively transfused non-surgical patients. This disparity may be 
attributable to the cause of bleeding being correctable with surgical intervention in the surgical 
population.   
 Similarly, Brown et al. (2012) performed a multicenter prospective cohort study using the 
Inflammation and the Host Response to Injury Large Scale Collaborative Program to evaluate 
adult patients with blunt injury and hemorrhagic shock who were between 18 and 90 years of age 
and received massive transfusion (10 or more units of RBCs within 24 hours of admission). A 
total of 604 patients met inclusion criteria. The study found an association between high early 
ratios of blood products (FFP/RBC 1:1.5 and PLT/RBC 1:9) and decreased patient mortality in 
the first 24 hours. Similarly, Holcomb et al. (2011) retrospectively examined ratios of PLT/RBC 
transfusion in 643 massively transfused trauma patients (10 units or more of RBCs within 24 
hours of admission) and mortality. The findings from this study support early transfusion of high 
ratio (defined in this study as 1:1) PLT/RBC transfusion in massively transfused patients.  
 Conversely, Sharpe et al. (2012) prospectively collected data to evaluate the effect of the 
number of RBC transfused on FFP/RBC and PLT/RBC ratio transfusion in 165 surgical trauma 
patients at Presley Regional Trauma Center. Activation of this protocol is based on clinician 
judgement rather than physiologic criteria. The protocol at this facility released 10 units of 
RBCs, 10 units of plasma, and 10 single-donor platelet units. Patients who were taken directly to 
surgery and received at least 10 units of RBCs by operation completion were included in the 
analysis; a total of 135 patients met the criteria. The average patient was 36 years of age and 
male. Sharpe et al. (2012) discovered that the more RBC units transfused, the less likely high 
component ratios were received by the end of the surgery. The reason for a lower ratio of product 
transfusion with increasing number of RBC units transfused was not clear. Patients who received 
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a higher number of RBC units and lower FFP/RBC transfusion ratio had an increased mortality 
risk.  
 The facility at which this case took place had a massive transfusion protocol (MTP) 
policy in place. The policy stated four reasons for activating the MTP: life-threatening trauma, 
unexpected surgical/obstetrical blood emergencies, surgeries expected to require massive 
transfusion, or others as determined (Sanford, 2016). The patient presented in this case report 
obviously met the criteria for massive transfusion. The MTP was not initiated until the vessel had 
been repaired. Prior to the vessel being repaired, several units of RBCs were transfused. Upon 
initiation of this facility’s MTP, packs of blood products are to be released every 45 minutes. The 
first pack is to contain: 4 units of RBCs, 4 units of FFP, and 1 unit of PLT. Cryoprecipitate 
requires time to be thawed and is initially released in the second MTP pack (Sanford, 2016).  
 Despite best efforts to prevent significant blood loss in the presented patient, massive 
bleeding was encountered. The bleeding was immediately recognized by the surgeon and quickly 
communicated to the anesthesia staff. Transfusion was without question indicated in the 
situation. The previously prepared units of RBCs as well as several additional units were 
transfused as urologic, general, and cardiothoracic surgeons repaired the IVC. Once the vessel 
was repaired, the MTP was activated and units of platelets and FFP were transfused along with 
more RBCs.  
Although not following high component ratio initially, as is supported by current 
literature, the patient had a good outcome. Perhaps this can be partially attributed to the fact that 
prior to repair of the IVC, the majority of transfused blood rapidly escaped from the vasculature, 
as was evidenced by the TEE. Once, the vessel was repaired, transfusion of other blood products 
was initiated. Considering this, perhaps the blood products which were retained intravascularly 
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had a higher ratio, which was sufficient in preventing hemodilution associated with high 
transfusion of RBCs without other components. 
Evidence Based Practice Recommendations 
Specific protocols or algorithms for intraoperative blood transfusion cannot be 
recommended at this time. Current transfusion guidelines, leave much room for practitioner 
discretion. Based on the current literature, restrictive transfusion is favorable, as transfusion of 
small perhaps discretionary amounts of blood has been shown to have adverse effects. If massive 
transfusion is required in the surgical patient, it is recommended to transfuse a “high” ratio of 
FFP/RBC and PLT/RBC. There is no clear-cut definition of high component ratios. In research, a 
high ratio of FFP/RBC has varied (1:1 - 1:2); however, a high ratio of PLT/RBC has ranged even 
more (1:1 - 1:9) (Brown et al., 2012; Holcomb et al., 2011; Sharpe et al., 2012). As such, 
massive transfusion protocols vary from facility to facility. It is advisable that anesthesia 
professionals be familiar with the MTP at the facility in which they practice.   
 Overall, the literature regarding the risk of bleeding in patients undergoing a radical 
nephrectomy and blood transfusion in cancer patients undergoing resection is extremely limited. 
Given the known potential involvement of vasculature with renal carcinoma and the risks of 
blood transfusion, especially in the immunocompromised, it is advisable that more research be 
performed on this topic. With more research, specific guidelines for this patient population may 
be developed to improve patient safety and enhance outcomes.  
Conclusion 
 Some bleeding during surgery is expected. Severe bleeding during surgery may lead to 
several complications, including death. However, transfusion of blood may also increase patient 
morbidity and mortality. Hence, it is important that anesthesia professionals are knowledgeable 
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about the current literature regarding blood transfusion in the surgical patient. Intervention starts 
with prevention; it is vital that anesthesia professionals work collaboratively with other members 
of the healthcare team to ensure patients have been optimized prior to undergoing elective 
surgery to decrease the chance of significant surgical bleeding. Preparation of patients may need 
to begin days or weeks prior to surgery. Secondly, it is important that anesthesia professionals 
identify when blood transfusion is warranted. Anesthesia professionals must carefully weigh the 
risks and benefits of blood transfusion for each patient individually to achieve best patient 
outcomes.  
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